Xavier Sastre‐Garau

18.9k citations

219 papers · 13.2k indexed · 3 hit papers · h-index 64

Oncology top 0.2%
Molecular Biology top 1%
Cancer Research top 0.2%
Pulmonary and Respiratory Medicine top 0.5%
Pathology and Forensic Medicine top 0.5%

Co-authors: Anne Vincent‐Salomon Brigitte Sigal‐Zafrani Olivier Delattre Jean Paul Thiery Alain Aurias François Radvanyi Bernard Asselain Patricia de Crémoux
Topics: Breast Cancer Treatment Studies (43 papers)Cancer Genomics and Diagnostics (31 papers)Cervical Cancer and HPV Research (31 papers)
Cited by: Cancer Research Oncology Pathology and Forensic Medicine
Journals: New England Journal of Medicine Journal of Clinical Investigation Nature Medicine
Partner nations: France United States Greece

In The Last Decade

Xavier Sastre‐Garau

217 papers receiving 12.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts

1994 816 citations Olivier Delattre, Xavier Sastre‐Garau et al. profile →
Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma.

1997 640 citations Xavier Sastre‐Garau et al. profile →
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas

1999 545 citations Xavier Sastre‐Garau, Jean Paul Thiery et al. profile →

Peers

Countries citing papers authored by Xavier Sastre‐Garau

Since Specialization

Citations

This map shows the geographic impact of Xavier Sastre‐Garau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Sastre‐Garau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Sastre‐Garau more than expected).

Fields of papers citing papers by Xavier Sastre‐Garau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Sastre‐Garau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Sastre‐Garau. The network helps show where Xavier Sastre‐Garau may publish in the future.

Co-authorship network of co-authors of Xavier Sastre‐Garau

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Sastre‐Garau. A scholar is included among the top collaborators of Xavier Sastre‐Garau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Sastre‐Garau. Xavier Sastre‐Garau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of the new molecular classification of endometrial cancer: A French cohort study 2022 ·Gynecologic Oncology ·(unknown),(unknown),Xavier Sastre‐Garau,(unknown),(unknown),Sofiane Bendifallah,Bassam Haddad,Cyril Touboul,(unknown),Yohann Dabi	4
2	Vulvar Basal Cell Carcinoma: Clinical and Histopathologic Features. 2022 ·PubMed ·(unknown),(unknown),(unknown),(unknown),Xavier Sastre‐Garau	1
3	Ovarian Cancers Harboring Inactivating Mutations in CDK12 Display a Distinct Genomic Instability Pattern Characterized by Large Tandem Duplications 2016 ·Cancer Research ·Tatiana Popova,Élodie Manié,Valentina Boeva,Aude Battistella,Oumou Goundiam,Nicholas K. Smith,Christopher R. Mueller,Virginie Raynal,Odette Mariani,Xavier Sastre‐Garau,Marc‐Henri Stern	79
4	Breast Cancer Cell–Derived GM-CSF Licenses Regulatory Th2 Induction by Plasmacytoid Predendritic Cells in Aggressive Disease Subtypes 2015 ·Cancer Research ·Cristina Ghirelli,Fabien Reyal,Marine Jeanmougin,Raphaël Zollinger,Philémon Sirven,Paula Michea,Christophe Caux,Nathalie Bendriss‐Vermare,Marie‐Hélène Donnadieu,Martial Caly,Virginie Fourchotte,Anne Vincent‐Salomon,Brigitte Sigal‐Zafrani,Xavier Sastre‐Garau,Vassili Soumelis	46
5	Mature Cytotoxic CD56bright/CD16 + Natural Killer Cells Can Infiltrate Lymph Nodes Adjacent to Metastatic Melanoma 2013 ·Cancer Research ·Meriem Messaoudene,Giulia Fregni,(unknown),J. Chanal,E. Maubec,(unknown),Benoît Couturaud,Angélique Girod,Xavier Sastre‐Garau,Sébastien Albert,C Guédon,Lydia Deschamps,Délphine Mitilian,Isabelle Cremer,Nicolas Jacquelot,Sylvie Rusakiewicz,Laurence Zitvogel,Marie‐Françoise Avril,Anne Caignard	79
6	Ploidy and Large-Scale Genomic Instability Consistently Identify Basal-like Breast Carcinomas with BRCA1/2 Inactivation 2012 ·Cancer Research ·Tatiana Popova,Élodie Manié,Guillaume Rieunier,Virginie Caux‐Moncoutier,Carole Tirapo,Thierry Dubois,Olivier Delattre,Brigitte Sigal‐Zafrani,Marc A. Bollet,Michel Longy,Claude Houdayer,Xavier Sastre‐Garau,Anne Vincent‐Salomon,Dominique Stoppa‐Lyonnet,Marc‐Henri Stern	418
7	Antibody-Dependent Cell Cytotoxicity Synapses Form in Mice during Tumor-Specific Antibody Immunotherapy 2011 ·Cancer Research ·Pascale Hubert,(unknown),Sophie Viel,Nicolás André,Xavier Sastre‐Garau,Pablo Oppezzo,Otto Pritsch,Eduardo Osinaga,Sebastián Amigorena	100
8	A transcriptome signature distinguished sporadic from postradiotherapy radiation-induced sarcomas 2011 ·Carcinogenesis ·(unknown),Nicolas Ugolin,(unknown),Nathalie Britzen‐Laurent,Xavier Sastre‐Garau,Sylvie Chevillard,Bernard Malfoy	41
9	Small-Molecule Drugs Mimicking DNA Damage: A New Strategy for Sensitizing Tumors to Radiotherapy 2009 ·Clinical Cancer Research ·Maria Quanz,Nathalie Berthault,(unknown),Maryline Roy,Aurélie Herbette,(unknown),Christophe Alberti,Véronique Josserand,Jean‐Luc Coll,Xavier Sastre‐Garau,Jean‐Marc Cosset,Lionel Larue,Jian‐Sheng Sun,Marie Dutreix	76
10	High Frequency of TP53 Mutation in BRCA1 and Sporadic Basal-like Carcinomas but not in BRCA1 Luminal Breast Tumors 2009 ·Cancer Research ·Élodie Manié,Anne Vincent‐Salomon,Jacqueline Lehmann‐Che,Gaëlle Pierron,Elisabeth Turpin,Mathilde Warcoin,Nadège Gruel,Ingrid Lebigot,Xavier Sastre‐Garau,Rosette Lidereau,Audrey Remenieras,Jean Feunteun,Olivier Delattre,Hugues de Thé,Dominique Stoppa‐Lyonnet,Marc‐Henri Stern	112
11	Homeostatic competition drives tumor growth and metastasis nucleation 2009 ·PubMed ·Markus Basan,Thomas Risler,Jean‐François Joanny,Xavier Sastre‐Garau,Jacques Prost	129
12	Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast 2008 ·Clinical Cancer Research ·Anne Vincent‐Salomon,Carlo Lucchesi,Nadège Gruel,Virginie Raynal,Gaëlle Pierron,(unknown),Fabien Reyal,François Radvanyi,Rémy Salmon,Jean Paul Thiery,Xavier Sastre‐Garau,Brigitte Sigal‐Zafrani,Alain Fourquet,Olivier Delattre,(unknown)	114
13	HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management? 2007 ·British Journal of Cancer ·Anne Vincent‐Salomon,J-Y Pierga,J Couturier,Catherine Dubois d’Enghien,Claude Nos,Brigitte Sigal‐Zafrani,Marick Laé,Paul Fréneaux,Véronique Dièras,Jean Paul Thiery,Xavier Sastre‐Garau	46
14	Neoadjuvant chemotherapy for invasive lobular carcinomas of the breast: a poorer response rate but not a worse prognosis than invasive ductal carcinoma 2005 ·Breast Cancer Research and Treatment ·Anne Vincent‐Salomon,(unknown),Chantal Gautier,Brigitte Sigal‐Zafrani,Paul Fréneaux,(unknown),Christophe Rosty,B Asselain,R.J. Salmon,Xavier Sastre‐Garau	9
15	Increased cell size and Akt activation in HER‐2/neu‐overexpressing invasive ductal carcinoma of the breast 2004 ·Histopathology ·Xavier Sastre‐Garau,Pierre Génin,Antoine Rousseau,Abir Al Ghuzlan,Nicolás André,Paul Fréneaux,Christophe Rosty,Brigitte Sigal‐Zafrani,J Couturier,Jean Paul Thiery,H Magdelénat,Anne Vincent‐Salomon	14
16	Modulation of tumor growth by inhibitory Fcγ receptor expressed by human melanoma cells 2002 ·Journal of Clinical Investigation ·Lydie Cassard,Joël F.G. Cohen-Solal,Annie Galinha,Xavier Sastre‐Garau,Claire Mathiot,Jérôme Galon,Thierry Dorval,Alain Bernheim,Wolf H. Fridman,Catherine Sautès‐Fridman	25
17	Quantitative PCR analysis of cerb B2 (HER2/neu) gene amplification and comparison with p185HER2neu protein expression in breast cancer drill biopsies 1999 ·International Journal of Cancer ·Patricia de Crémoux,(unknown),Anne Vincent‐Salomon,Véronique Dièras,(unknown),Stéphane Liva,P Pouillart,Xavier Sastre‐Garau,H Magdelénat	2
18	Papillomavirus humains et néoplasies génitales. 1998 ·Annales de Pathologie ·Xavier Sastre‐Garau	1
19	Infiltrating lobular carcinoma of the breast: Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns 1996 ·Cancer ·Xavier Sastre‐Garau,Michel Jouve,Bernard Asselain,Anne Vincent-Salomon,Philippe Beuzeboc,Thierry Dorval,J.C. Durand,(unknown),P Pouillart	327
20	Banque de tumeurs cryo-préservées dans le laboratoire d'Anatomie Pathologique. 1995 ·Annales de Pathologie ·Xavier Sastre‐Garau	2

About Xavier Sastre‐Garau

Xavier Sastre‐Garau is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 219 papers that have together received 13.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (43 papers), Cancer Genomics and Diagnostics (31 papers) and Cervical Cancer and HPV Research (31 papers). The work is most often cited by research in Cancer Research (3.7k citations), Oncology (5.4k citations) and Pathology and Forensic Medicine (2.1k citations). Xavier Sastre‐Garau has collaborated with scholars based in France, United States and Greece. Frequent co-authors include Anne Vincent‐Salomon, Brigitte Sigal‐Zafrani, Olivier Delattre, Jean Paul Thiery, Alain Aurias, François Radvanyi, Bernard Asselain, Patricia de Crémoux, Alain Fourquet and Philippe Terrier. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact